Insiders SIGN THERPAR

Equities

SIGY

US82674U2050

Market Closed - OTC Markets Other stock markets 09:57:32 15/05/2024 pm IST			5-day change	1st Jan Change
5.25 ^USD	+5.00%		+5.00%	+10.99%

20/02	Sigyn Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Sigyn Therapeutics, Inc. Appoints Jerry Deciccio as Chief Financial Officer	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sigyn Therapeutics, Inc. Appoints Jerry Deciccio as Chief Financial Officer	12/12	CI
Sigyn Therapeutics, Inc. Announces Appointment of Annette Marleau as Chief Scientific Officer	11/23/11	CI
Sigyn Therapeutics, Inc. Announces Board Changes, Effective October 10, 2022	04/22/04	CI
Sigyn Therapeutics Appoints Donald J. Hillebrand, M.D. to its Scientific Advisory Board	26/22/26	CI
Sigyn Therapeutics, Inc. Appoints Ajay Verma, M.D., Ph.D. to its Scientific Advisory Board	31/22/31	CI
Sigyn Therapeutics, Inc. Appoints H. David Humes, MD to Its Scientific Advisory Board	15/22/15	CI
Sigyn Therapeutics, Inc. Appoints Alexander S. Yevzlin to its Scientific Advisory Board	09/22/09	CI
Sigyn Therapeutics, Inc. Appoints Jeremy Ferrell as Chief Financial Officer, Effective March 9, 2022	02/22/02	CI
Sigyn Therapeutics, Inc. Appoints Eric Lynam as Head of Clinical Affairs	26/21/26	CI
Sigyn Therapeutics, Inc. Announces Executive Changes	24/20/24	CI
Reign Resources Corporation has Changed its Name to Sigyn Therapeutics, Inc	12/20/12	CI
Reign Resources Corporation and Sigyn Therapeutics, Inc. Announce Executive Changes	27/20/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW